We understand that recent events have prompted questions among professionals in our community. The ADA’s mission remains unchanged. Our work and commitments continue without interruption; no programs, events, or initiatives, including the 2027 Scientific Sessions, have been stalled, suspended, or stopped.
We also continue to actively accept and appropriately review all new and previously submitted manuscripts across ADA Journals (Diabetes Care, Diabetes, and Diabetes, Obesity, and CardioMetabolic CARE).
The ADA remains committed to serving the professional community and all people impacted by diabetes and obesity.
main content start
Innovation Challenge
Pay Application Fee
Complete your application by submitting a $350 non-refundable fee.
Thank you for submitting your application for the 2025 Innovation Challenge! Finalists will be notified by April 17.